- Becton, Dickinson ( NYSE: BDX ) and Magnolia Medical Technologies have teamed up to co-market Magnolia's Steripath Micro Initial Specimen Diversion Device platforms .
- Steripath complements BD's ( BDX ) Vacutainer push button and UltraTouch blood collection sets.
- CDC guidelines recommend use of initial specimen diversion devices that divert the initial 1 to 2 mL of potentially contaminated blood.
- Check out why Seeking Alpha contributor Andrew Harvey is bullish on BD ( BDX ).
For further details see:
Becton, Dickinson and Magnolia to collaborate on reducing blood culture contamination